A prescriber is considering pharmacogenetic testing (PGx) for a medication even though no alternative therapy exists.What issues should the nurse discuss with the prescriber?
A) If the test reveals the client to be a nonresponder,is it ethical to prescribe the medication anyway?
B) If the test inaccurately categorizes the client as a nonresponder and the medication is not prescribed,what are the implications?
C) If the client is sensitive to the drug and will experience adverse effects,should dosing be decreased?
D) If the client is a nonresponder to the medication,should that information be revealed to the client?
E) If the client is prescribed this medication,what follow-up schedule is necessary?
Correct Answer:
Verified
Q5: Which way of encouraging use of pharmacogenetic
Q6: A client is having genetic testing done
Q7: The nurse is discussing the current use
Q8: Which statement by a newly licensed nurse
Q9: The prescriber who follows the latest research
Q10: The nurse is evaluating the appropriateness of
Q11: The nurse will be responsible for the
Q12: A client asks the nurse how something
Q14: The benefits of pharmacogenetics (PGx)are documented.Which reasons
Q15: A client with breast cancer has had
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents